Last reviewed · How we verify
placebo of hydrocortisone plus fludrocortisone
placebo of hydrocortisone plus fludrocortisone is a Corticosteroid Small molecule drug developed by Centre Hospitalier Universitaire, Amiens. It is currently in Phase 3 development for Primary and secondary adrenal insufficiency.
This combination of hydrocortisone and fludrocortisone works by replacing deficient corticosteroids in the body.
This combination of hydrocortisone and fludrocortisone works by replacing deficient corticosteroids in the body. Used for Primary and secondary adrenal insufficiency.
At a glance
| Generic name | placebo of hydrocortisone plus fludrocortisone |
|---|---|
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Endocrinology |
| Phase | Phase 3 |
Mechanism of action
Hydrocortisone and fludrocortisone are corticosteroids that help replace the body's natural corticosteroids when they are deficient. This can help alleviate symptoms of adrenal insufficiency, such as fatigue, weight loss, and low blood pressure.
Approved indications
- Primary and secondary adrenal insufficiency
Common side effects
- Nausea
- Headache
- Fatigue
- Edema
- Hypertension
Key clinical trials
- Adjunctive Fludrocortisone in Septic Shock (PHASE2)
- FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage (PHASE2)
- Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis (NA)
- Hydrocortisone Plus Fludrocortisone in High-risk Patients Undergoing for Cardiac Surgery (PHASE3)
- Stress & Social Cognition in BPD (part 2) (NA)
- Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock. (PHASE3)
- Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension (PHASE4)
- Androgen Reduction in Congenital Adrenal Hyperplasia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo of hydrocortisone plus fludrocortisone CI brief — competitive landscape report
- placebo of hydrocortisone plus fludrocortisone updates RSS · CI watch RSS
- Centre Hospitalier Universitaire, Amiens portfolio CI
Frequently asked questions about placebo of hydrocortisone plus fludrocortisone
What is placebo of hydrocortisone plus fludrocortisone?
How does placebo of hydrocortisone plus fludrocortisone work?
What is placebo of hydrocortisone plus fludrocortisone used for?
Who makes placebo of hydrocortisone plus fludrocortisone?
What drug class is placebo of hydrocortisone plus fludrocortisone in?
What development phase is placebo of hydrocortisone plus fludrocortisone in?
What are the side effects of placebo of hydrocortisone plus fludrocortisone?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: Centre Hospitalier Universitaire, Amiens — full pipeline
- Therapeutic area: All drugs in Endocrinology
- Indication: Drugs for Primary and secondary adrenal insufficiency
- Compare: placebo of hydrocortisone plus fludrocortisone vs similar drugs
- Pricing: placebo of hydrocortisone plus fludrocortisone cost, discount & access